About our Founder
Stephen Cichy, Founder & Managing Director
Stephen’s background includes over 20 years of professional experience as an operator within the healthcare industry with specific focus on orphan drugs and related specialty biologics.
Under Stephen’s leadership, Monarch Specialty Group has developed a scalable growth partnership service model for the specialty pharmacy industry, including proprietary technology capabilities and a team with deep industry expertise. The Company’s unique innovation is to solve for the challenge of specialty drug distribution, coverage, and market access by linking clients with strategic decision making, actionable deal flow relationships, and real-world solutions for improved performance.
Prior to founding Monarch Specialty Group, he has held executive roles at several leading publicly-traded and private healthcare companies including BioScrip, Inc. (Specialty Pharmacy), Walgreens (Retail Pharmacy), Option Care, Inc. (Home Infusion Pharmacy), Caremark Rx, Inc. (PBM) and Takeda Pharmaceuticals, Inc. (Pharmaceutical Manufacturer).
Stephen is often quoted in the healthcare and business press, and is a frequent speaker at industry events. Stephen holds a B.A. in Biology from University of North Carolina.
Our Team Profiles
Howard Schwartz M.D., Managing Director
Dr. Schwartz’s role is to help enable ambitious market access goals for Monarch Specialty Group clients. In addition to medical practice, Dr. Schwartz’s experience includes leading over 1000 clinical trials in multiple therapeutic areas including gastroenterology, oncology, vaccines, women’s health, sleep medicine, weight loss, nutraceuticals, endocrinology, neurology, psychiatry, rheumatology, and pulmonary medicine.
Prior to joining Monarch Specialty Group, Dr. Schwartz served as Chief Medical Officer of QPS Holdings, and President of QPS MRA, its subsidiary. QPS is a US-based, international GLP/GCP-compliant contract research organization supporting discovery, preclinical and clinical drug development. Prior to its sale to QPS, Dr. Schwartz was the Chief Executive Officer and Medical Director of Miami Research Associates, Inc., a privately held multi-specialty clinical research organization serving the pharmaceutical industry.
Sebastiaan Abbink Spaink, Data Architect
Sebastiaan (“Bas”) is an Information Services professional with a unique expertise in big data, analytics, informatics, and infrastructure deploying HIPAA-secure systems designed for the healthcare industry. He is a strategic innovator who has built and deployed technology programs for diverse health organizations like NYU Langone Medical Center, American Red Cross and Ambio Health. Among various client responsibilities, Bas oversee’s Monarch Specialty Group’s data projects and technology investments including VoroniRx, a next-generation business intelligence tool for the specialty pharmacy industry.
Wendy Luo, Business Development & Client Liaison
Wendy is responsible for the support of new client development and administration, client implementation, and satisfaction. Wendy brings more than twelve years experience in working with pharmaceutical manufacturer businesses and related organizations achieve and sustain success. As an Associate with Monarch Specialty Group, Wendy works hard to unite our internal teams and client teams and partners toward a common project vision and goal regarding Monarch Specialty Group engagements.
Interested in Becoming an Associate?
We’re a thoughtful, tightly-knit team that’s committed to realizing ambitious goals for our clients.
All of our principals and associates have extensive background specific to specialty biologics, including:
- Prior executive management, M&A, and/or channel operating experience
- Access to proprietary deal flow
- Developed networks within specialty pharmacy and larger healthcare-investment community
- Demonstrated ability to create value for our clients